West Pharmaceutical Services Inc. (NYSE:WST) announced a quarterly dividend on Friday, December 22nd, Zacks reports. Investors of record on Thursday, January 18th will be paid a dividend of 0.14 per share by the medical instruments supplier on Thursday, February 1st. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date is Wednesday, January 17th.
West Pharmaceutical Services has increased its dividend payment by an average of 8.9% per year over the last three years and has increased its dividend annually for the last 25 consecutive years. West Pharmaceutical Services has a payout ratio of 20.3% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect West Pharmaceutical Services to earn $2.87 per share next year, which means the company should continue to be able to cover its $0.56 annual dividend with an expected future payout ratio of 19.5%.
Shares of West Pharmaceutical Services (NYSE:WST) opened at $99.09 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 2.59. West Pharmaceutical Services has a 52 week low of $77.97 and a 52 week high of $103.36. The company has a market capitalization of $7,360.00, a price-to-earnings ratio of 39.48, a P/E/G ratio of 2.07 and a beta of 1.12.
West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, October 26th. The medical instruments supplier reported $0.67 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.14. West Pharmaceutical Services had a return on equity of 14.47% and a net margin of 12.12%. The business had revenue of $398.20 million during the quarter, compared to analysts’ expectations of $386.02 million. During the same period in the previous year, the firm earned $0.53 earnings per share. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. analysts anticipate that West Pharmaceutical Services will post 2.76 EPS for the current year.
WST has been the subject of a number of analyst reports. Jefferies Group raised West Pharmaceutical Services from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $96.00 to $115.00 in a research note on Friday, September 15th. Stephens initiated coverage on West Pharmaceutical Services in a research note on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price objective for the company. Zacks Investment Research raised West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Wednesday, September 27th. Bank of America cut West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price objective for the company. in a research note on Tuesday, October 17th. Finally, Wells Fargo & Co lifted their price objective on West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a research note on Friday, October 27th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. West Pharmaceutical Services has a consensus rating of “Hold” and an average target price of $106.00.
In other West Pharmaceutical Services news, CFO William J. Federici sold 21,000 shares of the business’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $99.01, for a total value of $2,079,210.00. Following the completion of the transaction, the chief financial officer now directly owns 190,493 shares of the company’s stock, valued at $18,860,711.93. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.90% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This news story was reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://transcriptdaily.com/2018/01/12/west-pharmaceutical-services-inc-wst-declares-quarterly-dividend-of-0-14.html.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.